ReviewThe oncologist2021

A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 Study.

John M Varlotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.